Pay in 4 interest-free payments of $7.18 Learn more
Ships within 48 hours · Estimated delivery Aug 22 - Aug 27
Retatrutide 10mg The 10mg vial format of retatrutide, Eli Lilly's triple GLP-1/GIP/glucagon receptor agonist, offering greater dosing flexibility for metabolic research protocols targeting weight loss, insulin resistance, and hepatic fat
The company brought in $13 billion in revenue in 2025, but its net loss reportedly ballooned nearly eight-fold to $39 billion last year from $5 billion in 2024
Sermorelin is provided as a compounded preparation
Normal albumin levels are between 4 and 5 g/dL
Nonetheless, mazdutide and tirzepatide carry warnings about medullary thyroid carcinoma and are contraindicated in patients with personal or family history of this rare cancer or multiple endocrine neoplasia syndrome type 2
This helps stabilize the ingredients and the product
US$ 21.34
US$ 28.00
US$ 29.20
